USPTO serial 99034644
IMPS
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- PRIZANT, JAMES
- Law office
- TMO LAW OFFICE 135
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with IMPS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Los Angeles, CA, US
Los Angeles, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Howard W. Kline
Howard W. Kline NATH, GOLDBERG & MEYER112 S. West StreetAlexandria, VA 22314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; Stem cells for scientific purposes; Stem cells, other than for medical or veterinary purposes; all the foregoing excluding insulin-like growth factor 2 (IGF2) messenger RNA (mRNA) binding proteins (IGF2BPs) | ACTIVE | — |
| 005 | Stem cells for medical purposes; Living cells for medical use; Cells for medical use; Biological preparations for use in cell cultures for medical purposes; all the foregoing excluding insulin-like growth factor 2 (IGF2) messenger RNA (mRNA) binding proteins (IGF2BPs) | ACTIVE | — |
| 042 | Stem cell research services; Medical and scientific research in the field of stem cell therapy; Medical and scientific research information in the field of stem cell therapy; but not including services in relation to insulin-like growth factor 2 (IGF2) messenger RNA (mRNA) binding proteins (IGF2BPs) | ACTIVE | — |
| 044 | Medical services, namely, stem cell therapy procedures; Medical services in the field of stem cell therapy; but not including services in relation to insulin-like growth factor 2 (IGF2) messenger RNA (mRNA) binding proteins (IGF2BPs) | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BHC MANAGEMENT, LLC
- Other trademarks owned by BHC MANAGEMENT, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IMPS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 12, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 11, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 11, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 11, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 26, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 31, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 26, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 21, 2025 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jul 21, 2025 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jul 21, 2025 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Jul 21, 2025 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Jul 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 10, 2025 | NWAP | NEW APPLICATION ENTERED | — |
| Feb 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |